Lucas Energy, Inc. (NYSEMKT:LEI)

Lucas Energy, Inc. is an independent oil and gas company building a diversified portfolio of valuable oil and gas assets in the United States. The company is focused on identifying underperforming oil and gas assets, which are revitalized through a meticulous process of evaluation, application of modern well technology, and stringent management controls. This process allows the company to increase its asset base and cash flow, while significantly reducing the risk of traditional exploration projects.

Lucas Energy, Inc. (NYSEMKT:LEI)’s Financial Overview

Lucas Energy, Inc. (NYSEMKT:LEI) surged 27.5% yesterday to close its trading session at $1.53. The company has 1 year Price Target of $1. Lucas Energy, Inc. has 52-Week high of $10.65 and 52-Week Low of $0.84. The stock touched its 52-Week High on Dec 31, 2015 and 52-Week Low on Nov 9, 2016. The stock traded with the volume of 8.55 Million shares yesterday. The firm shows the market capitalization of $28.4 Million.

The firm is trading with SMA20 of 29.18 Percent, SMA50 of -19.46 Percent and SMA200 of -53.19 percent. Lucas Energy, Inc. has P/S value of 21.84 while its P/B value stands at 4.37. Similarly, the company has Return on Assets of -220.6 percent, Return on Equity of 0 percent and Return on Investment of -254.3 Percent. The company shows Gross Margin and Operating Margin of 17.3 percent and 0 percent respectively.

The Stock currently has Analyst’ mean Recommendation of 4 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 1 analysts offering 12-month price forecasts for Lucas Energy Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a -34.64% decrease from the last price of 1.53.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

Curis, Inc. (NASDAQ:CRIS)

Curis, Inc. is a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, with technologies that utilize regulatory pathways that control repair and regeneration. Curis’ product development involves the use of small molecules or proteins to modulate these pathways. The company has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of cancer, neurological disorders, hair growth, kidney and other diseases, as well as cardiovascular disease.

Curis, Inc. (NASDAQ:CRIS)’s Financial Outlook

The 4 analysts offering 12-month price forecasts for Curis Inc have a median target of 6.50, with a high estimate of 7.00 and a low estimate of 5.00. The median estimate represents a +124.91% increase from the last price of 2.89.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, Curis, Inc. has a Consensus Recommendation of 1. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock fell -6.17% and closed its last trading session at $2.89. The company has the market capitalization of $406.16 Million. The stock has 52-week high of $3.72 and 52-Week low of $1.25. The firm touched its 52-Week high on Nov 15, 2016 and 52-Week low on Feb 11, 2016. The company has volume of 1.71 Million shares. The company has a total of 140.54 Million shares outstanding.

Curis, Inc. (NASDAQ:CRIS) in the last quarter reported its actual EPS of $-0.21/share where the analyst estimated EPS was $-0.1/share. The difference between the actual and Estimated EPS is $-0.11. This shows a surprise factor of -110 percent.

The company has YTD performance of -0.69 percent. Beta for Curis, Inc. stands at 1.97 while its ATR (average true range) is 0.21. The company has Weekly Volatility of 5.68%% and Monthly Volatility of 8.33%%.

Curis, Inc. has distance from 20-day Simple Moving Average (SMA20) of -7.04%, Distance from 50-Day Simple Moving Average of 0.13 percent and Distance from 200-Day Simple Moving Average of 43.83%.

The Company currently has ROA (Return on Assets) of -78 percent, Return on Equity (ROE) of -122.3 Percent and Return on Investment (ROI) of -63.7% with Gross margin of 94.8 percent and Operating & Profit margin of 0% and 0% respectively.